Assistant Professor, Radiology and Imaging Sciences, Emory University School of Medicine
Radiology
Dr. David M. Schuster, MD
|
|
Give Review
David Schuster practices Radiology. He graduated from Albany Medical College. David Schuster is also published. He has 57 publications published. The lastest publication: "Esophageal scarring causing false-positive uptake on I-131 whole-body imaging.' David Schuster accepts Medicare payments and is listed with Medicare.gov.
Publications
- Is there a role for PET/CT parameters to differentiate thyroid cartilage invasion from penetration?
- [(14)C]Fluciclovine (alias anti-[(14)C]FACBC) uptake and ASCT2 expression in castration-resistant prostate cancer cells.
- Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques.
- 18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?
- The Nuclear Medicine Therapy Care Coordination Service: A Model for Radiologist-Driven Patient-Centered Care.
- Octreoscan Versus FDG-PET for Neuroendocrine Tumor Staging: A Biological Approach.
- Anti-1-Amino-3-18F-Fluorocyclobutane-1-Carboxylic Acid: Physiologic Uptake Patterns, Incidental Findings, and Variants That May Simulate Disease.
- Reproducibility and Reliability of Anti-3-[(18)F]FACBC Uptake Measurements in Background Structures and Malignant Lesions on Follow-Up PET-CT in Prostate Carcinoma: an...
- Anti-3-[(18)F]FACBC Positron Emission Tomography-Computerized Tomography and (111)In-Capromab Pendetide Single Photon Emission Computerized Tomography-Computerized Tom...
- A Simple Method for Estimating Dose Delivered to Hepatocellular Carcinoma after Yttrium-90 Glass-based Radioembolization Therapy: Preliminary Results of a Proof of Con...
- Local Recurrence Patterns in Breast Cancer Patients Treated with Oncoplastic Reduction Mammaplasty and Radiotherapy.
- Quantitative Dosimetry for Yttrium-90 Radionuclide Therapy: Tumor Dose Predicts Fluorodeoxyglucose Positron Emission Tomography Response in Hepatic Metastatic Melanoma.
- Differences in Neural Activation for Object-Directed Grasping in Chimpanzees and Humans.
- Four-dimensional (4D) Motion Detection to Correct Respiratory Effects in Treatment Response Assessment Using Molecular Imaging Biomarkers.
- Pilot Study of the Utility of the Synthetic PET Amino-Acid Radiotracer Anti-1-Amino-3-[(18)F]Fluorocyclobutane-1-Carboxylic Acid for the Noninvasive Imaging of Pulmona...
- Imaging quality of F-18-FDG PET/CT in the inpatient versus outpatient setting.
- Accuracy Evaluation of a 3D Ultrasound-guided Biopsy System.
- Radiation field design and patterns of locoregional recurrence following definitive radiotherapy for breast cancer.
- Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake.
- Hyperspectral imaging and quantitative analysis for prostate cancer detection.
- Transport mechanisms of trans-1-amino-3-fluoro[1-(14)C]cyclobutanecarboxylic acid in prostate cancer cells.
- Unusual presentations of metastatic prostate carcinoma as detected by anti-3 F-18 FACBC PET/CT.
- Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents.
- Biodistribution and human dosimetry of enantiomer-1 of the synthetic leucine analog anti-1-amino-2-fluorocyclopentyl-1-carboxylic acid.
- Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT.
- Pilot evaluation of anti-1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinoma.
- MR-based attenuation correction for hybrid PET-MR brain imaging systems using deformable image registration.
- Prompt-gamma compensation in Rb-82 myocardial perfusion 3D PET/CT.
- Initial experience with the radiotracer anti-1-amino-3-[18F]Fluorocyclobutane-1-carboxylic acid (anti-[ 18F]FACBC) with PET in renal carcinoma.
- Breast angiosarcoma: FDG PET findings.
- Case study of anti-1-amino-3-F-18 fluorocyclobutane-1-carboxylic acid (anti-[F-18] FACBC) to guide prostate cancer radiotherapy target design.
- Investigation of emission-transmission misalignment artifacts on rubidium-82 cardiac PET with adenosine pharmacologic stress.
- Sarcoid-like reaction in the spleen following chemotherapy for non-Hodgkin's lymphoma.
- Biodistribution and radiation dosimetry of the synthetic nonmetabolized amino acid analogue anti-18F-FACBC in humans.
- Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma.
- Radionuclide imaging for hyperparathyroidism (HPT): which is the best technetium-99m sestamibi modality?
- Choroidal melanoma with hematogenous spread to the liver: F-18 FDG PET/CT findings.
- Gastrointestinal tract malignancies and positron emission tomography: an overview.
- Xanthogranulomatous pyelonephritis characterized on PET/CT.
- Central line injection artifact simulating paratracheal adenopathy on FDG PET imaging.
- Molecular imaging in breast cancer.
- CT with histopathologic correlation of FDG uptake in a patient with pulmonary granuloma and pleural plaque caused by remote talc pleurodesis.
- Involving users in the implementation of an imaging order entry system.
- Gallium and other agents in diseases of the lung.
- PET-CT vs contrast-enhanced CT: what is the role for each after chemoradiation for advanced oropharyngeal cancer?
- The use of the diagnostic radionuclide ascites scan to facilitate treatment decisions for hepatic hydrothorax.
- The malady of incomplete, inadequate, and inaccurate radiology requisition histories: a computerized treatment.
- Jejunal diverticular hemorrhage localized by red blood cell scintigraphy.
- Malignant supraclavicular lymph node visualization during Tc-99m HDP bone imaging.
- Indeterminate adrenal masses.
- Posterior bladder layering of excreted 18F-FDG on PET/CT.
- Absent coronary artery calcium excludes inducible myocardial ischemia on computed tomography/positron emission tomography.
- F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer.
- Esophageal scarring causing false-positive uptake on I-131 whole-body imaging.
- Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer.
- Artifactual perfusion defect from a hypertrophic first costosternal articulation.
Schools
Albany Medical College
Albany Med Center Hospital
Tufts New England Med Center
Emory University Hospital
Doctors Specialties
- Nuclear Radiology
- Radiology
Accepted Insurances
Education
-
Tufts Medical Center -
Albany Medical Center -
Albany Medical College
Hospital
-
Emory University Hospital -
Grady Memorial Hospital -
Emory University Hospital Midtown
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1265497176 |
| Last Name Of The Provider | SCHUSTER |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. Dale F. Nordenberg, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce Baumgartner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arthur J. Fountain Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sadhna B. Nandwana, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Veronica Solis, MD |
|
|
Dr. Hamilton E. Reavey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Oluwayemisi Ibraheem, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kiery A. Braithwaite, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William A. Fajman, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Marielle A. Johary, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Travis J. Langley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan M. Loewen, MD |